WallStSmart
ATOS

Atossa Genetics Inc

NASDAQ: ATOS · HEALTHCARE · BIOTECHNOLOGY

$5.37
+1.70% today

Updated 2026-04-30

Market cap
$49.09M
P/E ratio
P/S ratio
1,872.06x
EPS (TTM)
$-4.04
Dividend yield
52W range
$4 – $19
Volume
0.1M

Atossa Genetics Inc (ATOS) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-75176.00$-358111.00$-3.49M$-3.90M$-8.83M$-10.56M$-13.95M$-5.37M$-6.59M$-8.96M$-9.13M$-11.57M$-16.47M$-20.76M$-20.94M$-21.03M$-29.76M
Capital expenditures$4.00$0.00$136931.00$134582.00$489815.00$343257.00$130735.00$9213.00$110906.00$110906.00$7628.00$9367.00$9000.00$27000.00$14000.00$19000.00$23000.00
Depreciation
Stock-based comp$30396.00$140056.00$121812.00$1.44M$698657.00$840103.00$876189.00$786550.00$2.46M$8.84M$3.02M$5.27M$6.79M$4.62M$2.29M$2.65M
Free cash flow$-75180.00$-358111.00$-3.63M$-4.03M$-9.32M$-10.90M$-14.08M$-5.38M$-6.70M$-9.07M$-9.14M$-11.58M$-16.48M$-20.79M$-20.95M$-21.05M$-29.79M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$4.50M
Share repurchases
Debt repayment
Net change in cash$-185624.00$4.62M$2.16M$-4.78M$-687933.00$4.19M$3.22M$2.20M$26.97M$96.82M$-25.49M